Search Results 8681-8690 of 40674 for oral

1. Kristina A. Butler, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   This study is to investigate the clinical usefulness of Gleolan (aminolevulinic acid hydrochloride, 5-ALA), an oral agent for the detection and visualization of ...

2. Comprehensive Stroke Measure - Mayo Clinic

   Patients receiving oral anticoagulants, as well as those with an acquired or congenital coagulopathy, are at increased risk for ICH and hemorrhagic ...

3. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

   Use of bisphosphonates (oral or IV) or denosumab within 2 years prior to Visit 1. 9. Non-hypocalcemic seizure disorder with a history of a seizure within 26 ...

4. Salivary gland tumors - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

5. MC1R-targeted Alpha-particle Monotherapy And Combination Therapy Trial With Nivolumab In Adults With Advanced Melanoma - Mayo Clinic

   * Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...

6. Nurse Practitioner or Physician Assistant Urology Fellowship (Minnesota) - Health Sciences Education

   Mayo Clinic School of Health Sciences offers the 12-month postgraduate Nurse Practitioner or Physician Assistant Urology Fellowship in Rochester, Minnesota.

7. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

8. A Study Of APG-2575 Alone Or In Combination With Other Therapeutic Agents To Treat Relapsed And/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

   Hormonal contraceptives (oral, parenteral, vaginal ring or transdermal) for at least 3 months prior to study drug administration. If hormonal contraceptives ...

9. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   ... oral, implanted, or injectable contraceptive hormones or mechanical products such as intrauterine device or barrier methods (diaphragm, condoms, spermicides) ...

10. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

    Inability to tolerate the administration of an oral inhaled powder via DPI. 9. Has taken any investigational product within 30 days or 5 half lives of the ...